Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes (POEMS) Syndrome in the Middle East: A Case Report
PDF

Keywords

POEMS syndrome
Plasma cell dyscrasia
Osteosclerotic myeloma
PEP syndrome
Case report

Categories

Date

How to Cite

1.
Hassan MA, N. ElWakil R, Abukandil I, et al. Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes (POEMS) Syndrome in the Middle East: A Case Report. ASIDE Case Reports. 2025;2(2):1-4. doi:10.71079/ASIDE.CR.091725195

Abstract

POEMS syndrome is a rare paraneoplastic syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal protein gammopathy, and skin changes. We report the first case of POEMS syndrome in Egypt. We report a 37-year-old Egyptian male who presented with left lower limb pain, numbness, weight loss, and urinary incontinence. Laboratory evaluation revealed monoclonal IgA lambda bands and 10\% plasma cells on bone marrow aspiration. Nerve conduction studies confirmed severe sensory-motor polyneuropathy with axonal degeneration. Bone scan showed sclerotic changes, and imaging revealed hepatosplenomegaly. The patient met the diagnostic criteria for POEMS syndrome and was treated with the VRD protocol. Follow-up over 23 months showed declining M-band levels with eventual normalization. However, β2-microglobulin levels rose. The patient achieved a partial response and was referred for autologous bone marrow transplantation. This represents the first reported case of POEMS syndrome in Egypt, emphasizing the need for clinical awareness in non-endemic regions. A multidisciplinary approach is essential for optimal management. Further studies are needed to explore the presentation and management of POEMS syndrome in the Middle East and North Africa region.

PDF

References

1. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood. 2003: 2496 [PMID: 12456500, https://doi.org/10.1182/blood-2002-07-2299]

2. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med. 1992: 1919 [PMID: 1333569, https://doi.org/10.1056/NEJM199212313272705]

3. Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984: 712 [PMID: 6539431, https://doi.org/10.1212/wnl.34.6.712]

4. Crow RS. Peripheral neuritis in myelomatosis. Br Med J. 1956: 802 [PMID: 13364332, https://doi.org/10.1136/bmj.2.4996.802]

5. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore). 1980: 311 [PMID: 6248720, https://doi.org/10.1097/00005792-198007000-00006]

6. Suichi T, Misawa S, Beppu M, Takahashi S, Sekiguchi Y, Shibuya K, Amino H, Tsuneyama A, Suzuki YI, Nakamura K, Sato Y, Kuwabara S. Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey. Neurology. 2019: e975 [PMID: 31371568, https://doi.org/10.1212/WNL.0000000000008062]

7. Gherardi RK, Belec L, Soubrier M, Malapert D, Zuber M, Viard JP, Intrator L, Degos JD, Authier FJ. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood. 1996: 1458 https://doi.org/10.1182/blood.V87.4.1458.bloodjournal8741458]

8. Lesprit P, Godeau B, Authier FJ, Soubrier M, Zuber M, Larroche C, Viard JP, Wechsler B, Gherardi R. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med. 1998: 907 [PMID: 9517610, https://doi.org/10.1164/ajrccm.157.3.9707095]

9. Kanai K, Sawai S, Sogawa K, Mori M, Misawa S, Shibuya K, Isose S, Fujimaki Y, Noto Y, Sekiguchi Y, Nasu S, Nakaseko C, Takano S, Yoshitomi H, Miyazaki M, Nomura F, Kuwabara S. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology. 2012: 575 [PMID: 22843279, https://doi.org/10.1212/WNL.0b013e318263c42b]

10. Dispenzieri A. POEMS syndrome: Update on diagnosis, risk-stratification, and management. Am J Hematol. 2023: 1934 [PMID: 37732822, https://doi.org/10.1002/ajh.27081]

11. Gavriatopoulou M, Musto P, Caers J, Merlini G, Kastritis E, van de Donk N, Gay F, Hegenbart U, Hajek R, Zweegman S, Bruno B, Straka C, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M, Terpos E. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia. 2018: 1883 [PMID: 30038381, https://doi.org/10.1038/s41375-018-0209-7]

12. Benbella I, ElAsri H, Rifai S, Mahmoud M, Boukhrissi FE. POEMS Syndrome: A Case Report and Literature Review. Saudi Journal of Medicine. 2022: 88 https://doi.org/10.36348/sjm.2022.v07i01.015]

13. Ouzzif Z, Doghmi K, Messaoudi N, Bouhsain S, El Machtani S, Biaz A, Rachid A, Dami A, Bezza A, El Maataoui A. Epidemiology of monoclonal gammopathy in Morocco - A hospital-based study. Cancer Rep (Hoboken). 2023: e1814 [PMID: 36999311, https://doi.org/10.1002/cnr2.1814]

14. Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol. 1983: 543 [PMID: 6315993,

15. Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, Ohmori S, Mitsuma S, Koga S, Kuwabara S. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2012: 476 [PMID: 22338030, https://doi.org/10.1136/jnnp-2011-301706]

16. Wang Y, Huang LB, Shi YH, Fu H, Xu Z, Zheng GQ, Wang Y. Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study. Front Immunol. 2019: 1428 [PMID: 31293587, https://doi.org/10.3389/fimmu.2019.01428]

17. Kanuganti D, Nagarjunakonda VS, Bandarupalli P, Gorijala VK, Konagalla V, Kowtha P. POEMS Syndrome: A Case Report and Review of the Literature. Cureus. 2022: e27001 [PMID: 35989837, https://doi.org/10.7759/cureus.27001]

18. Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med. 1994: 543 [PMID: 7985714, https://doi.org/10.1016/0002-9343(94)90350-6]

19. Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, Zhao YQ, Shen T. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol. 2011: 819 [PMID: 21221584, https://doi.org/10.1007/s00277-010-1149-0]

20. Mauermann ML, Sorenson EJ, Dispenzieri A, Mandrekar J, Suarez GA, Dyck PJ, Dyck PJ. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurg Psychiatry. 2012: 480 [PMID: 22396441, https://doi.org/10.1136/jnnp-2011-301472]

21. Zhou GX, Xiao L, Bi YM, Yang F, Yang CZ, Zhang D. Case report: POEMS syndrome masquerades as diabetic foot. Front Neurol. 2023: 1336382 [PMID: 38344111, https://doi.org/10.3389/fneur.2023.1336382]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Malak A. Hassan, Rodina N. ElWakil, Islam Abukandil, Mina Soryal, Abdelrahman Zaki, Mohamed Mahmoud Marey, Ashraf Elghandour